The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
December 2nd 2024
Ustekinumab-kfce is planned for launch in February 2025 according to a previous settlement and license agreement with Janssen.
November 27th 2024
November 26th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Proposed Physician Fee Schedule Update Implements Reform Provisions
CMS published its annual regulatory update to the Medicare Physician Fee Schedule, including rules implementing key provisions of the Affordable Care Act.
Health Care Reform: Guidance on Claims and Appeals Rules
Interim final rules clarify the scope of internal claims and appeals procedures and external review processes under PPACA.
Meeting the challenge of chronicshoulder pain: The diagnosis
July 31st 2010Shoulder pain is complex and difficult for even experienced clinicians to diagnose. This article reviews how to use history, simple physical tests, and imaging to distinguish rotator cuff disorders and osteoarthritis from osteonecrosis, adhesive capsulitis, labral tears, or acromioclavicular joint pathology.
Low back pain management: Approaches to treatment
July 31st 2010anagement of low back pain (LBP) includes a variety of approaches. The clinician should involve patients in the discussion and encourage them to become active participants. Bed rest has many deleterious effects; remaining active is more effective for patients with acute or subacute LBP.
Current concepts in corticosteroid-induced bone disease
July 31st 2010The most common secondary form of osteoporosis is corticosteroid-induced disease. Cases of endogenous corticosteroid excess are few compared with the large number produced by exogenous use of the drug for management of many diverse diseases.
Broader osteoporosis screening guideline drafted
July 29th 2010Screening for osteoporosis should be conducted for all women 65 years and older and for younger women whose fracture risk is equal to or greater than that of a 65-year-old woman who has no additional risk factors, according to a US Preventive Services Task Force (USPSTF) recommendation statement draft.
Evaluating RA disease severity: Patients and physicians do not see eye to eye
July 28th 2010Close to one-third of patients with rheumatoid arthritis (RA) differ from their physicians in their assessment of disease severity, according a University of California, San Francisco study. Researchers found that patients who have depressive symptoms or poor overall function disagree with their physicians in their evaluation of RA activity more frequently than those who do not.
OCR Issues Proposed Modifications to HIPAA Privacy and Security Rules to Implement HITECH Act
On July 14, 2010, the Office for Civil Rights (OCR) of the U.S. Department of Health and Human Services (HHS), issued a proposed rule containing modifications to the privacy standards, security standards, and enforcement regulations under HIPAA.
Following Exercise Recommendations Improves Pain in OA Patients
July 28th 2010Sticking to a physical therapy exercise routine or maintaining a physically active lifestyle can help patients with osteoarthritis improve the pain, physical function, and self-perceived effect, according to the results of a study by Dutch researchers.
Glenohumeral osteoarthritis treatment guideline released
July 27th 2010Total shoulder arthroplasty (TSA) should not be performed in patients with glenohumeral osteoarthritis (GHOA) who have an irreparable rotator cuff tear, and physicians should use perioperative mechanical or chemical venous thromboembolism prophylaxis for patients who have undergone shoulder arthroplasty.
Oral Calcitonin Product Advances
July 23rd 2010The ORACAL trial of Tarsa Therapeutics, Inc.'s oral calcitonin product has completed patient enrollment in a multinational, randomized, double-blind, placebo-controlled Phase III trial. The product is for the treatment of postmenopausal osteoporosis. Additionally, the trial completed two separate safety reviews of patient data by an independent data monitoring committee and is set to proceed as planned.